BSE

Swiss based Pharma Veteran, Balasubramanian Srinivasan (Srini Srinivasan) joins TAKE Solutions Board as an Independent Director

Chennai, December 07, 2019: TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a globally recognized domain intensive services provider in Life…

5 years ago

India pharmaceuticals market expected to reach USD 73.5 billion by 2023

Mumbai, April 08, 2019: Market Research Future (MRFR) in its latest analysis titled, “Withering USFDA inspections: The Quality Challenge for…

6 years ago

Diabetes major Eris Lifesciences joins hands with Medtronic for diabetes monitoring initiative

Mumbai, January 04, 2018: In a first of its kind collaborative initiative in India between a pharmaceutical and medical device company,…

6 years ago

Cipla announces Q2 FY19 results

Mumbai, November 28, 2018: Cipla Limited (BSE: 500087, NSE: CIPLA) today announced its unaudited consolidated financial results for quarter ended September…

6 years ago

Sun Pharma arm to acquire shares of Israeli firm Tarsius Pharma

New Delhi, September 10, 2018: Drug major Sun Pharmaceutical Industries Monday said it has agreed to acquire 18.75 per cent…

6 years ago

AstraZeneca Pharma India gets DCGI nod to market cancer drug in India

New Delhi, August 18, 2018: Drug firm AstraZeneca Pharma India today said it has received permission from the Drug Controller General of India (DCGI) to import and market olaparib tablets…

6 years ago

Kilitch Drugs eyes African markets to fuel growth

Setup of manufacturing unit on 12400 sqm of land in Ethiopia  Mumbai, August 08, 2018: Kilitch Drugs (India) Ltd,a fast…

6 years ago

Aurobindo gets USFDA nod for antibiotic

Mumbai, August 04, 2018: Aurobindo Pharma said on 5 June it has received approval from the US Food and Drug…

6 years ago

Lupin Goa plant gets U.K. nod

New Delhi, July 16, 2018: Lupin on Monday said it had received approval from the U.K. health regulator for its Goa…

6 years ago

Fortis surges on nod for stake buy

New Delhi, July 14, 2018: Shares of Fortis Healthcare rose by 4 per cent after its board approved a T4,000…

6 years ago